Best Practice & Research Clinical Haematology
Volume 19, Issue 1 , Pages 35-49, March 2006

Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease

  • Cassandra D. Josephson, MD (Assistant Director, Children's Healthcare of Atlanta Blood Banks and Transfusion Services; Assistant Professor, Pathology and Laboratory Medicine and Pediatrics)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 404 785 4553; Fax: +1 404 785 1370.
  • Thomas C. Abshire, MD (Professor of Pediatrics and Director, Comprehensive Hemophilia Program)

Division of Hematology/Oncology/Bone Marrow Transplant, Pathology; Laboratory Medicine; Pediatrics, Emory University School of Medicine, 2015 Uppergate Dr. NE, Atlanta, GA 30322, USA

AFLAC Cancer Center and Blood Disorders Service, Emory University School of Medicine, Atlanta, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(05)00032-0

doi:10.1016/j.beha.2005.01.031

Best Practice & Research Clinical Haematology
Volume 19, Issue 1 , Pages 35-49, March 2006

Article Tools